openPR Logo
Press release

Animal Healthcare Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

10-27-2017 06:08 AM CET | Health & Medicine

Press release from: Pharamceutical

Animal Healthcare Market – Global Industry Insights, Trends,

Animal healthcare has turned its focus area by the animal medicine industry because of increase in animal disease, vaccination, animal adoption and livestock. The global animal healthcare market is expected to gain major traction, on the backdrop of increasing pet adoption and high consumption of milk and meat. There is an increase in adoption of western culture and dynamic lifestyle in emerging countries such as India and China, which in turn has increased the pet adoption that is expected to favor the rise in growth for animal healthcare market. Pets are adopted by people all over the world for psychological and therapeutic benefits. An increase in new animal diseases such as white nose syndrome and anthrax has created opportunities in the animal healthcare market. Globally, Australia holds the leading position in pet ownership. According to the Australian Veterinary Association, there were around 4.2 million dogs and 3.3 million cats accounting for 39% and 29% market share respectively.

Request a sample pdf Copy of report @ https://www.coherentmarketinsights.com/insight/request-sample/550

Animal healthcare market taxonomy

By Animal Type

Livestock Animal
Companion Animal
By Product Type

Vaccination
Pharmaceuticals
Feed Additives
By Disease Type

Bacterial Disease
Fungal Disease
Genetic Disease
Viral Disease
Pet adoption and increase in livestock fuels the growth of animal healthcare market

According to the Animal Health Institute, in the U.S., on an average, the world spends around one fortieth amount to human medicine as compared with animal medicines every year. That investment covers animal health innovations for 24 billion chickens, 750 million swine, 500 million dogs, 400 million cats and 1 billion cattle and sheep. According to Animal Health Institute, companies yearly invest around 10-12% of their sales in innovations for animal health. Scientists have developed various medicines which result in improvement, prevention, and treatment of animal diseases such as flea and tick infestation, rabies, Lyme disease, leukemia. Animal medicines are important in food safety as it accounts for production animal as well. According to the American Society for the Prevention of Cruelty to Animals, in U.S., approximately 3.2 million shelter animals adopted each year, which includes 1.6 million dogs and 1.6 million cats. According to American Pet Product Association, in U.S. from 2015 to 2016, 34% dogs are purchased from breeders at the same time 23% of dogs and 31% of cats are obtained from the animal shelter. Globally the adoption of pets has increased over a period of time and demand for meat and milk also has increased to support the growing population which is expected to fuel the animal healthcare market in the near future.

Developed regions are major growth engines of animal healthcare market

Globally the market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. According to American Pet Product Association, during 2013-2014 North America is the leading market and it contributes around 68% owning the pet population has triple in from 2009 to 2014 in North America followed by Europe with a population of pets around 62 million and Asia Pacific due to the adoption of western lifestyle and increase in animal adoption. North America and Europe will be the largest market of vaccine and pharmaceuticals. Asia-Pacific will be the largest market for feed additives. In Asia Pacific, It is expected that pharmaceutical and vaccine segment will grow at a faster rate due to increased animal adoption and increased demand of meat and milk. According to IIPTF, in India 600,000 pets are adopted every year.

Ask for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/550

Key players of animal healthcare market

There are various animal healthcare market players are present all over the world. Animal healthcare industry has seen some major merger and acquisitions to develop new drugs. In 2016, Sanofi and Boehringer Ingelheim merger have taken place to develop new and improved drugs for animal healthcare. Some of the key market players of animal healthcare market includes Zoetis, Eli Lilly & Co., Novartis, Bayer Healthcare, Ceva Sante Animale, Evonik Industries AG, and ADM Alliance Nutrition.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
E-mail : sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Animal Healthcare Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025 here

News-ID: 788911 • Views: 577

More Releases from Pharamceutical

Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin …
Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these
New improved medication with lesser side effects will drive the insomnia therape …
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period. Intermezzo (2014), are used in small doses and administered
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market Regional Analysis North America and Europe are expected to witness significant growth in the market over the forecast period due to robust pipeline for epilepsy treatment and individual efforts by leading manufacturers. For instance, Pfizer, Inc. entered into partnership with Epilepsy Foundation to find solutions for generic forms of epilepsy and associated neurological disorders in 2014. Asia Pacific region is expected to show positive developments over the forecast

All 5 Releases